Frontiers | miR-125a Induces HER2 Expression and Sensitivity to Trastuzumab in Triple-Negative Breast Cancer Lines | Oncology
Cetuximab intensifies cisplatin-induced testicular toxicity - ppt download
Findings from Can-Fite's Phase II Liver Cancer Study were Presented at ASCO Annual Meeting Late-Breaking Session | Business Wire
Transnational cancer research lab | Felsenstein Medical Research Center
OncologyEducation on Twitter: "Dr. Salomon Stemmer provides an update of Namodenoson in patients with Child-Pugh B hepatocellular carcinoma in this video from #ASCO19: https://t.co/82i6FiEBcN… https://t.co/3aAVqpqbMy"
Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy | npj Breast Cancer
Prof.Salomon Stemmer
GRAPES: A CANCER CELL INHIBITOR?
Transnational cancer research lab | Felsenstein Medical Research Center
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Collaterals
Oncology Education | Videos
GRAPES: A CANCER CELL INHIBITOR?
PDF) Posttraumatic Growth in Breast Cancer Survivors: Constructive and Illusory Aspects | Ruth Pat-Horenczyk, Shlomit Perry, Yuval Ziv, Salomon Stemmer, and Yaira Hamama-raz - Academia.edu
肿瘤专家团队- 垒登健康科技
The association between infections and chemotherapy interruptions among cancer patients: Prospective cohort study
New Long-Term Outcomes Data Reconfirm Value of Oncotype DX Breast Recurrence Score® Test to Target Chemotherapy | WebMagspace
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Transnational cancer research lab | Felsenstein Medical Research Center
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
PLOS ONE: Factors Affecting Communication Patterns between Oncology Staff and Family Members of Deceased Patients: A Cross-Sectional Study
Ribociclib Improves Progression-Free Survival for Women with Metastatic Breast Cancer
The value of source data verification in a cancer clinical trial
